PATRICIA ESMERALDA
CARREIRA DELGADO
Profesora asociada de Ciencias de la Salud
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (41)
2021
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
Reumatologia Clinica, Vol. 15, Núm. 1, pp. 34-42
2018
-
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study
Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 370-381
-
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 563-570
-
Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol
Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 91-97
-
There is a need for new systemic sclerosis subset criteria. A content analytic approach
Scandinavian Journal of Rheumatology, Vol. 47, Núm. 1, pp. 62-70
-
Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study
Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 98-105
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 270-276
-
Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)
Annals of the Rheumatic Diseases, Vol. 76, Núm. 7, pp. 1207-1218
-
Update of EULAR recommendations for the treatment of systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Clinical and Experimental Rheumatology, Vol. 34, pp. 92-99
-
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway
Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
Arthritis and Rheumatology
-
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis
American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61